<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672603</url>
  </required_header>
  <id_info>
    <org_study_id>UGFS-01</org_study_id>
    <nct_id>NCT04672603</nct_id>
  </id_info>
  <brief_title>Complete Versus Partial Preservation of Denonvilliers' Fascia on Urogenital Function in Locally Advanced Rectal Cancer</brief_title>
  <official_title>Effects of Complete Preservation Versus Partial Preservation of Denonvilliers' Fascia on Postoperative Urogenital Function in Locally Advanced Non-anterior Mid-low Rectal Cancer Patients：A Multicenter，Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sixth Affiliated Hospital, Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total mesorectal resection (TME) is the standard surgical method for locally advanced rectal&#xD;
      cancer, which significantly reduces the local recurrence rate. However, the incidence of&#xD;
      urogenital dysfunction is higher. Studies found that Denonvilliers' Fascia contains autonomic&#xD;
      nerves that may regulate urogenital function, while traditional TME surgery resects part of&#xD;
      it. Recent Studies found that complete preservation of Denonvilliers' Fascia could improve&#xD;
      urogenital in selected patients with rectal cancer. Locally advanced patient (T3-4 and/or N+,&#xD;
      M0) accounts for a high proportion of mid-low rectal cancer. However, whether these patients&#xD;
      can benefit from it has not fully been demonstrated. This project conducts a multi-center&#xD;
      randomized controlled study to evaluate the effects of complete preservation and partial&#xD;
      preservation of Denonvilliers' Fascia on postoperative urogenital function of locally&#xD;
      advanced non-anterior mid-low rectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of sexual dysfunction</measure>
    <time_frame>1 month</time_frame>
    <description>IIEF-5(International questionnaire of erectile function-5), Ejaculation function and FSFI questionnaires are used to assess sexual function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of urinary dysfunction</measure>
    <time_frame>1 month</time_frame>
    <description>IPSS(International prostate symptom score), ICIQ, bladder residual urine volume and urodynamic study are used to assess urinary function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of sexual dysfunction</measure>
    <time_frame>9 months</time_frame>
    <description>IIEF-5, Ejaculation function and FSFI questionnaires are used to assess sexual function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of urinary dysfunction</measure>
    <time_frame>9 months</time_frame>
    <description>IPSS, ICIQ questionnaires, bladder residual urine volume and urodynamic study are used to assess urinary function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed with GIQLI questionnaires</measure>
    <time_frame>1month</time_frame>
    <description>GIQLI questionnaires are used to assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed with GIQLI questionnaires</measure>
    <time_frame>9 months</time_frame>
    <description>GIQLI questionnaires are used to assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-year local recurrence</measure>
    <time_frame>1 year</time_frame>
    <description>1-year local recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-year overall survival rate</measure>
    <time_frame>1 year</time_frame>
    <description>1-year overall survival rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive Circumferential Resection Margin Rate</measure>
    <time_frame>1 week</time_frame>
    <description>Positive Circumferential Resection Margin Rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">214</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Advanced Cancer</condition>
  <arm_group>
    <arm_group_label>Complete Preservation of Denonvilliers Fascia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Complete preservation of Denonvilliers fascia in Laparoscopy-assisted pelvic autonomic nerve preservation surgery with TME for mid-low rectal cancer patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partial Preservation of Denonvilliers Fascia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Partial preservation of Denonvilliers fascia in Laparoscopy-assisted pelvic autonomic nerve preservation surgery with TME for mid-low rectal cancer patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Complete Preservation of Denonvilliers' Fascia</intervention_name>
    <description>Patients accept L-PANP surgery with complete preservation of Denonvilliers Fascia</description>
    <arm_group_label>Complete Preservation of Denonvilliers Fascia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pathological diagnosis of rectal adenocarcinoma;&#xD;
&#xD;
          2. Preoperative staging cT3-4 and or N+，M0 rectal cancer (AJCC- 7th);&#xD;
&#xD;
          3. Non-anterior wall, mid-low rectal cancer from 0 to 12 cm from the anal verge measured&#xD;
             by rigid proctoscope;&#xD;
&#xD;
          4. R0 surgical results is expected by transabdominal or transanal TME/TSME;&#xD;
&#xD;
          5. 18 &lt; age (years) &lt; 71, informed consent;&#xD;
&#xD;
          6. Normal erection function (IIEF-5&gt;21), ejaculation function grading as I level, FSFI &gt;&#xD;
             26, normal urinary function (Bladder residual urine&lt;100ml);&#xD;
&#xD;
          7. Preoperative ASA grade I ~ III, no serious systemic disease;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Preoperatively confirmed peritoneum or distant metastasis;&#xD;
&#xD;
          2. Intraoperative confirmed invasion of surrounding tissues or organs, cannot be R0&#xD;
             resected;&#xD;
&#xD;
          3. With other malignant diseases;&#xD;
&#xD;
          4. With acute ileus, perforation or hemorrhage,need emergency surgery;&#xD;
&#xD;
          5. Critical organs dysfunction, unable to tolerate laparoscopic surgery;&#xD;
&#xD;
          6. With severe mental illness, cannot be evaluated;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>71 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bing Zeng, M.D.</last_name>
    <phone>8613450366467</phone>
    <email>zengbing3@mail.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sixth Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510655</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bing Zeng, M.D.</last_name>
      <phone>8613450366467</phone>
      <email>zengbing3@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urogenital Function</keyword>
  <keyword>Denonvilliers' Fascia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

